ライブ

IlluminaThe Bull Case For Illumina (ILMN) Could Change Following Upgraded 2026 Outlook And Major Buyback - Learn Why - simplywall.st FierceBiotechFDA Commissioner Marty Makary to resign, capping turbulent tenure: report FierceBiotechKyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis Clinical OMICsLow‑Dose Digoxin Shows Benefit in Heart Failure Treatment Clinical OMICsAntibody Promotes Nerve Regeneration in Spinal Cord Injury Patients Clinical OMICsSingle Procedure Reduces Colorectal Cancer Risk Decades Later 10x Genomics News10x Genomics settles suit with rival and targets DNA sequencing startup - Life Sciences Intellectual Property Review Clinical OMICsFirst Clinical Trial for a GLP-1 Gene Therapy Greenlit in Europe BioPharma DiveFDA chief Marty Makary resigns from agency, ending tumultuous tenure Endpoints NewsEU reaches provisional deal on Critical Medicines Act Endpoints NewsFDA Commissioner Makary to resign, source says Endpoints NewsIran war disruptions begin to emerge upstream of the pharma supply chain

Clinical OMICs 2026年5月12日

Antibody Promotes Nerve Regeneration in Spinal Cord Injury Patients

Spinal cord injury patients could benefit from treatment with an antibody that blocks a protein called Nogo-A that normally suppresses nerve regrowth in the cen...

Spinal cord injury patients could benefit from treatment with an antibody that blocks a protein called Nogo-A that normally suppresses nerve regrowth in the central nervous system. The post Antibody Promotes Nerve Regeneration in Spinal Cord Injury Patients appeared first on Inside Precision Medicine .